SCHEMBL6710147

SCHEMBL6710147

CC(=O)Oc1ccc2c(C(=O)Nc3ccc(C#N)cc3-c3nnn[nH]3)noc2c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.34
POLB P06746 1/20 0.34
MAPT P10636 1/20 0.34
HIF1A Q16665 8/20 0.34
KDM4E B2RXH2 3/20 0.32
GLA P06280 3/20 0.32
GAA P10253 3/20 0.32
ALDH1A1 P00352 2/20 0.32
HPGD P15428 1/20 0.32
CASP1 P29466 1/20 0.32
CASP7 P55210 1/20 0.32
HSD17B10 Q99714 1/20 0.32
RXFP1 Q9HBX9 1/20 0.31
LMNA P02545 1/20 0.31
CYP1A2 P05177 1/20 0.31
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
GPR6 P46095 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6710321 0.92 MAPT (0.42) TP53POLBMAPTHIF1AALDH1A1
SCHEMBL6713264 0.87 GPR35 (0.39) POLBHIF1AKDM4EGLAGAA
SCHEMBL6710363 0.87 HIF1A (0.39) POLBMAPTHIF1AKDM4EGLA
SCHEMBL6710167 0.86 ESR1 (0.38) HIF1ALMNACYP1A2LRRK2
SCHEMBL6711918 0.86 HIF1A (0.36) TP53POLBMAPTHIF1AKDM4E
SCHEMBL6710001 0.85 HIF1A (0.34) HIF1ALRRK2
SCHEMBL6707637 0.85 HIF1A (0.39) MAPTHIF1ACYP1A2MEN1KMT2A
SCHEMBL6710401 0.85 ALPL (0.39) TP53POLBMAPTHIF1A
SCHEMBL6713551 0.85 MAOB (0.38) MAPTGAAALDH1A1HPGDLRRK2
SCHEMBL6709888 0.84 HIF1A (0.47) HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed
WO-2004018461-A2 ANTIBACTERIAL BENZOIC ACID DERIVATIVES PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 TP53 2699/4885POLB 626/4885MAPT 4754/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.